|
| Index | - | P/E | - | EPS (ttm) | -1.02 | Insider Own | 8.50% | Shs Outstand | 8.82M | Perf Week | 21.85% |
| Market Cap | 15.18M | Forward P/E | - | EPS next Y | -1.27 | Insider Trans | 0.00% | Shs Float | 6.19M | Perf Month | -16.36% |
| Income | -8.60M | PEG | - | EPS next Q | -0.34 | Inst Own | 4.70% | Short Float | 1.72% | Perf Quarter | -17.49% |
| Sales | 10.10M | P/S | 1.50 | EPS this Y | -43.20% | Inst Trans | 18.67% | Short Ratio | 0.27 | Perf Half Y | -53.88% |
| Book/sh | 2.87 | P/B | 0.64 | EPS next Y | -0.80% | ROA | -29.40% | Target Price | 9.42 | Perf Year | -68.17% |
| Cash/sh | 2.87 | P/C | 0.64 | EPS next 5Y | 15.00% | ROE | -36.20% | 52W Range | 1.51 - 28.98 | Perf YTD | -76.44% |
| Dividend | - | P/FCF | - | EPS past 5Y | - | ROI | - | 52W High | -93.65% | Beta | - |
| Dividend % | - | Quick Ratio | - | Sales past 5Y | - | Gross Margin | 57.50% | 52W Low | 21.85% | ATR | 0.25 |
| Employees | 59 | Current Ratio | 13.40 | Sales Q/Q | -20.70% | Oper. Margin | -84.20% | RSI (14) | 43.50 | Volatility | 31.71% 12.57% |
| Optionable | No | Debt/Eq | 0.14 | EPS Q/Q | -37.50% | Profit Margin | -84.90% | Rel Volume | 0.87 | Prev Close | 1.65 |
| Shortable | Yes | LT Debt/Eq | 0.12 | Earnings | Aug 04 BMO | Payout | - | Avg Volume | 393.16K | Price | 1.84 |
| Recom | 2.00 | SMA20 | -9.02% | SMA50 | -17.00% | SMA200 | -53.89% | Volume | 343,933 | Change | 11.52% |
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
| open in yahoo | open in reuters | open in marketwatch | open in google |
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite